Skip to main content

Imerys Agrees To Settle Asbestos-related Mesothelioma Case

Imerys Agrees To Settle Asbestos-related Mesothelioma Case

Imerys Agrees To Settle Asbestos-related Mesothelioma Case

Introduction

Johnson & Johnson’s Talcum powder supplier Imerys Talc America has agreed to settle the claims made by a plaintiff that years of using their asbestos-contaminated Baby Powder caused her mesothelioma. Imerys has confessed to the allegation that it knowingly sold the adulterated product to the public. During the closing arguments on September 13, the plaintiff’s attorney asked the California jury for $29 million in damages for the alleged lung cancer. The woman states she used the baby powder for nearly 40 years, and like millions of other individuals, she blames the company for falsely marketing the product as safe to use.

Many women have also filed lawsuits over asbestos-in-talc causing ovarian cancer when used for personal hygiene purposes. J&J faces more than 10,000 claims over these allegations, the trials for which are underway in several state courts this month.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!